| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 566 |
| 1 | IPILIMUMAB | 347 |
| 2 | CARBOPLATIN | 188 |
| 3 | PACLITAXEL | 134 |
| 4 | LEVOTHYROXINE SODIUM | 100 |
| 5 | BEVACIZUMAB | 99 |
| 6 | PREDNISONE | 97 |
| 7 | DURVALUMAB | 87 |
| 8 | FUROSEMIDE | 77 |
| 9 | CYCLOPHOSPHAMIDE | 74 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZINC CREAM | 1 | 0.0625 |
| 1 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 2 | BEVACIZUMAB-ADCD | 2 | 0.0099 |
| 3 | ESTRONE | 1 | 0.0093 |
| 4 | PROCAINAMIDE HYDROCHLORIDE | 2 | 0.0081 |
| 5 | IPILIMUMAB | 347 | 0.0079 |
| 6 | MINOCYCLINE | 69 | 0.0059 |
| 7 | NIVOLUMAB | 566 | 0.0058 |
| 8 | CHORIONIC GONADOTROPIN | 3 | 0.0053 |
| 9 | TREMELIMUMAB | 23 | 0.0052 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 365 | 0.0076 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 567 | 0.0058 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 87 | 0.0040 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 29 | 0.0030 |
| 4 | Thyroid Stimulating Hormone [EPC] | 3 | 0.0029 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 52 | 0.0027 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 13 | 0.0021 |
| 7 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 8 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 9 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |